Avidity Biosciences, Inc. - Common Stock (RNA)

Historical Holders from Q2 2020 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
RNA on Nasdaq
Shares outstanding
149,544,182
Price per share
$72.13
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
160,908,041
Total reported value
$7,009,352,759
% of total 13F portfolios
0.01%
Share change
+24,836,488
Value change
+$1,158,003,556
Number of holders
268
Price from insider filings
$72.13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Avidity Biosciences, Inc. - Common Stock (RNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 9.6% $575,984,900 13,219,759 The Vanguard Group 30 Sep 2025
PRICE T ROWE ASSOCIATES INC /MD/ 7.1% $426,459,326 9,787,912 T. Rowe Price Associates, Inc. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 8.1% $247,730,942 9,684,556 Wellington Management Group LLP 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P. 5.9% $376,489,721 8,641,031 RA Capital Management, L.P. 30 Sep 2025
BlackRock, Inc. 6.4% -14% $376,086,262 -$17,916,333 8,631,771 -4.5% BlackRock, Inc. 30 Sep 2025
JANUS HENDERSON GROUP PLC 5.5% -47% $582,654,041 -$446,149,257 8,224,930 -43% JANUS HENDERSON GROUP PLC 28 Nov 2025
RTW INVESTMENTS, LP 3.1% $204,173,813 4,686,110 RTW Investments, LP 27 Oct 2025
FMR LLC 2.1% -86% $128,911,093 -$809,934,537 2,958,712 -86% FMR LLC 31 Oct 2025
As of 30 Sep 2025, Avidity Biosciences, Inc. - Common Stock (RNA) has 268 institutional shareholders filing 13F forms. They hold 160,908,041 shares. .

Top 25 institutional shareholders own 91% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
FMR LLC 14% 21,585,984 +33% 0.05% $940,501,305
JANUS HENDERSON GROUP PLC 9.7% 14,522,915 +35% 0.29% $632,808,722
VANGUARD GROUP INC 8.8% 13,219,759 +43% 0.01% $575,984,899
RTW INVESTMENTS, LP 7.6% 11,372,829 +18% 6.1% $495,514,160
WELLINGTON MANAGEMENT GROUP LLP 6.7% 10,065,187 +8.8% 0.08% $438,540,198
PRICE T ROWE ASSOCIATES INC /MD/ 6.5% 9,787,417 -9.4% 0.05% $426,438,000
BlackRock, Inc. 6.2% 9,202,579 -1.4% 0.01% $400,956,371
RA CAPITAL MANAGEMENT, L.P. 5.8% 8,641,031 +19% 4.6% $376,489,721
Avoro Capital Advisors LLC 5.1% 7,645,000 +8.4% 4.3% $333,092,650
STATE STREET CORP 3.3% 4,888,632 +16% 0.01% $212,997,696
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,858,049 +0.35% 0.01% $124,547,400
Polar Capital Holdings Plc 1.9% 2,796,760 +58% 0.59% $121,854,833
Bellevue Group AG 1.4% 2,152,862 1.9% $93,800,197
Casdin Capital, LLC 1.2% 1,780,000 +0.28% 6.5% $77,554,600
GOLDMAN SACHS GROUP INC 1.2% 1,732,469 +51% 0.01% $75,483,675
BANK OF AMERICA CORP /DE/ 1.2% 1,725,186 -6.2% 0.01% $75,166,353
ORBIMED ADVISORS LLC 1.1% 1,638,886 -9.6% 1.7% $71,406,263
T. Rowe Price Investment Management, Inc. 0.94% 1,401,906 +72% 0.04% $61,082,000
Pictet Asset Management Holding SA 0.89% 1,338,091 +38% 0.06% $58,234,125
UBS Group AG 0.88% 1,315,859 +121% 0.01% $57,331,977
Siren, L.L.C. 0.86% 1,285,610 +16% 2.2% $56,014,028
Fiera Capital Corp 0.8% 1,202,384 +54% 0.17% $52,387,871
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.8% 1,200,000 -21% 0.08% $52,284,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.75% 1,123,777 +7.2% 0.01% $48,962,964
NORTHERN TRUST CORP 0.65% 975,056 -2.2% 0.01% $42,483,191

Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 36,731 $2,648,998 -$2,255,117 $72.13 7
2025 Q3 160,908,041 $7,009,352,759 +$1,158,003,556 $43.57 268
2025 Q2 135,973,420 $3,861,676,519 +$69,697,386 $28.40 205
2025 Q1 133,409,266 $3,962,055,230 +$178,441,325 $29.52 218
2024 Q4 127,627,892 $3,712,315,565 -$47,544,719 $29.08 232
2024 Q3 125,172,698 $5,747,409,921 +$525,069,616 $45.93 239
2024 Q2 111,915,111 $4,571,747,454 +$938,345,183 $40.85 191
2024 Q1 89,244,556 $2,277,452,184 +$379,403,859 $25.52 155
2023 Q4 99,877 $903,886 -$575,553 $9.05 2
2023 Q3 5,222,237 $33,317,494 -$4,349,883 $6.38 14
2023 Q2 82,372,581 $913,513,101 +$45,839,333 $11.09 138
2023 Q1 75,905,578 $1,164,984,161 +$45,103,010 $15.35 136
2022 Q4 71,605,495 $1,588,949,850 +$414,642,652 $22.19 145
2022 Q3 53,371,282 $871,633,746 -$46,945,339 $16.33 116
2022 Q2 51,915,279 $754,358,370 +$37,157,871 $14.53 100
2022 Q1 46,909,430 $866,282,187 +$27,212,352 $18.47 93
2021 Q4 45,391,487 $1,078,920,735 +$3,605,438 $23.77 101
2021 Q3 44,394,930 $1,093,340,317 +$239,536,085 $24.63 109
2021 Q2 34,467,030 $851,504,705 +$17,357,609 $24.71 92
2021 Q1 33,888,820 $739,146,337 +$60,776,521 $21.81 97
2020 Q4 30,821,303 $786,587,311 +$74,431,621 $25.52 81
2020 Q3 27,020,375 $755,387,115 +$43,761,743 $28.15 66
2020 Q2 25,458,553 $701,864,000 +$701,298,980 $28.26 52